Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Hamburg FDA image

FDA boasts better approval rates than Europe

November 4, 2011 Medical Communications, Research and Development FDA, approvals

US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …
News

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …
Appointment

Richard Daniell appointed as managing director of Teva UK

November 2, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …
Appointment
Sanofi HQ pic

Sanofi to become world’s biggest drug maker

November 2, 2011 Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …
News
pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011 Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …
News
picture_2

Lundbeck appoints two new R&D vice presidents

November 1, 2011 Research and Development Lundbeck, R&D

Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …
Appointment
Obama image

Obama takes action to curb medicine shortages

November 1, 2011 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs

US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …
News
Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …
Feature

Contract research news in brief

October 31, 2011 Manufacturing and Production, Research and Development CRO, manufacturing and production

PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …
News
Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011 Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …
News
NICE building

Mepact wins NICE backing

October 26, 2011 Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …
News
Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011 Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …
News

David Meeker appointed as chief executive of Genzyme

October 25, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Appointment

New venture a ‘game-changer’ for pharma

October 25, 2011 Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …
News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011 Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026